When was ExtruPharm founded?

ExtruPharm was founded in 2018.

Where is ExtruPharm located?

ExtruPharm is headquartered in Southbridge, United States.

Is ExtruPharm a funded company?

ExtruPharm is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does ExtruPharm rank among its competitors?

ExtruPharm ranks 1273rd amongst 1343 active competitors, of which 26 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of ExtruPharm?

ExtruPharm's top competitors include Indegene, IntegriChain and Prescient Healthcare Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

ExtruPharm - 2026 Company Profile & Competitors

Most viewed in 2019

ExtruPharm is an unfunded company based in Southbridge (United States), founded in 2018. It operates as a Provider of consulting and packaging services to biopharma sector. ExtruPharm has not raised any funding yet. The company has 1343 active competitors, including 26 funded and 147 that have exited. Its top competitors include companies like Indegene, IntegriChain and Prescient Healthcare Group.

Key Metrics

Founded Year

2018

Location

Southbridge, United States

Stage

Unfunded

Ranked

1273^rd among 1343 active competitors

Similar Companies

Indegene & 1602 more

View ExtruPharm's full profile

ExtruPharm has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ExtruPharm include Indegene, IntegriChain and Prescient Healthcare Group. Here is the list of Top 10 competitors of ExtruPharm, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Intertrust, Bridgepoint Group & 8 others	60/100
4th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, HSBC & 3 others	59/100
5th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	56/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
9th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
10th	Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded	Provider of diversified consulting services for biopharma sector	-	-	49/100
1273rd	ExtruPharm 2018, Southbridge (United States), Unfunded	Provider of consulting and packaging services to biopharma sector	-	-	16/100